These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 21974719)

  • 21. Moyamoya disease in a patient with hereditary spherocytosis.
    Holz A; Woldenberg R; Miller D; Kalina P; Black K; Lane E
    Pediatr Radiol; 1998 Feb; 28(2):95-7. PubMed ID: 9472053
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic analysis of
    Tashiro R; Fujimura M; Sakata H; Endo H; Tomata Y; Sato-Maeda M; Niizuma K; Tominaga T
    Neurol Res; 2019 Sep; 41(9):811-816. PubMed ID: 31064275
    [No Abstract]   [Full Text] [Related]  

  • 23. Intracranial carotid artery stent placement causes delayed severe intracranial hemorrhage in a patient with moyamoya disease.
    Eicker S; Etminan N; Turowski B; Steiger HJ; Hänggi D
    J Neurointerv Surg; 2011 Jun; 3(2):160-2. PubMed ID: 21990810
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of Interethnic Difference of Collateral Angioarchitectures on Prevalence of Hemorrhagic Stroke in Moyamoya Disease.
    Hori S; Kashiwazaki D; Yamamoto S; Acker G; Czabanka M; Akioka N; Kuwayama N; Vajkoczy P; Kuroda S
    Neurosurgery; 2019 Jul; 85(1):134-146. PubMed ID: 29889273
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Associations of Moyamoya patients with HLA class I and class II alleles in the Korean population.
    Han H; Pyo CW; Yoo DS; Huh PW; Cho KS; Kim DS
    J Korean Med Sci; 2003 Dec; 18(6):876-80. PubMed ID: 14676447
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cav-1 (Caveolin-1) and Arterial Remodeling in Adult Moyamoya Disease.
    Chung JW; Kim DH; Oh MJ; Cho YH; Kim EH; Moon GJ; Ki CS; Cha J; Kim KH; Jeon P; Yeon JY; Kim GM; Kim JS; Hong SC; Bang OY
    Stroke; 2018 Nov; 49(11):2597-2604. PubMed ID: 30355208
    [TBL] [Abstract][Full Text] [Related]  

  • 27. What is the expert's option on antiplatelet therapy in moyamoya disease? Results of a worldwide Survey.
    Kraemer M; Berlit P; Diesner F; Khan N
    Eur J Neurol; 2012 Jan; 19(1):163-7. PubMed ID: 21771204
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Moyamoya disease: a summary.
    Burke GM; Burke AM; Sherma AK; Hurley MC; Batjer HH; Bendok BR
    Neurosurg Focus; 2009 Apr; 26(4):E11. PubMed ID: 19335127
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The clinical features of adult unilateral moyamoya disease: does it have the same clinical characteristics as typical moyamoya disease?
    Ogata T; Yasaka M; Inoue T; Yasumori K; Ibayashi S; Iida M; Okada Y
    Cerebrovasc Dis; 2008; 26(3):244-9. PubMed ID: 18648196
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetics of Moyamoya disease.
    Roder C; Nayak NR; Khan N; Tatagiba M; Inoue I; Krischek B
    J Hum Genet; 2010 Nov; 55(11):711-6. PubMed ID: 20739943
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sibling cases of moyamoya disease having homozygous and heterozygous c.14576G>A variant in RNF213 showed varying clinical course and severity.
    Miyatake S; Touho H; Miyake N; Ohba C; Doi H; Saitsu H; Taguri M; Morita S; Matsumoto N
    J Hum Genet; 2012 Dec; 57(12):804-6. PubMed ID: 22931863
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nationwide survey on quasi-moyamoya disease in Japan.
    Hayashi K; Horie N; Izumo T; Nagata I
    Acta Neurochir (Wien); 2014 May; 156(5):935-40. PubMed ID: 24499994
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human leukocyte antigen in patients with moyamoya disease.
    Aoyagi M; Ogami K; Matsushima Y; Shikata M; Yamamoto M; Yamamoto K
    Stroke; 1995 Mar; 26(3):415-7. PubMed ID: 7886716
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vessel Wall Thickening and Enhancement in High-Resolution Intracranial Vessel Wall Imaging: A Predictor of Future Ischemic Events in Moyamoya Disease.
    Kathuveetil A; Sylaja PN; Senthilvelan S; Kesavadas C; Banerjee M; Jayanand Sudhir B
    AJNR Am J Neuroradiol; 2020 Jan; 41(1):100-105. PubMed ID: 31896569
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DIAPH1 Variants in Non-East Asian Patients With Sporadic Moyamoya Disease.
    Kundishora AJ; Peters ST; Pinard A; Duran D; Panchagnula S; Barak T; Miyagishima DF; Dong W; Smith H; Ocken J; Dunbar A; Nelson-Williams C; Haider S; Walker RL; Li B; Zhao H; Thumkeo D; Marlier A; Duy PQ; Diab NS; Reeves BC; Robert SM; Sujijantarat N; Stratman AN; Chen YH; Zhao S; Roszko I; Lu Q; Zhang B; Mane S; Castaldi C; López-Giráldez F; Knight JR; Bamshad MJ; Nickerson DA; Geschwind DH; Chen SL; Storm PB; Diluna ML; Matouk CC; Orbach DB; Alper SL; Smith ER; Lifton RP; Gunel M; Milewicz DM; Jin SC; Kahle KT
    JAMA Neurol; 2021 Aug; 78(8):993-1003. PubMed ID: 34125151
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Familial occurrence of moyamoya disease in the mother and four daughters including identical twins.
    Kaneko Y; Imamoto N; Mannoji H; Fukui M
    Neurol Med Chir (Tokyo); 1998 Jun; 38(6):349-54. PubMed ID: 9689818
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RNF213 p.R4810K Variant and Intracranial Arterial Stenosis or Occlusion in Relatives of Patients with Moyamoya Disease.
    Matsuda Y; Mineharu Y; Kimura M; Takagi Y; Kobayashi H; Hitomi T; Harada KH; Uchihashi Y; Funaki T; Miyamoto S; Koizumi A
    J Stroke Cerebrovasc Dis; 2017 Aug; 26(8):1841-1847. PubMed ID: 28506590
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Arterial spin-labeling MR imaging in Moyamoya disease compared with clinical assessments and other MR imaging findings.
    Noguchi T; Kawashima M; Nishihara M; Hirai T; Matsushima T; Irie H
    Eur J Radiol; 2013 Dec; 82(12):e840-7. PubMed ID: 24055185
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Accelerated intracranial occlusive disease, oral contraceptives, and cigarette use.
    Levine SR; Fagan SC; Pessin MS; Silbergleit R; Floberg J; Selwa JF; Vogel CM; Welch KM
    Neurology; 1991 Dec; 41(12):1893-901. PubMed ID: 1745344
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical features and outcome in North American adults with idiopathic basal arterial occlusive disease without moyamoya collaterals.
    Goyal MS; Hallemeier CL; Zipfel GJ; Rich KM; Grubb RL; Chicoine MR; Moran CJ; Cross DT; Dacey RG; Derdeyn CP
    Neurosurgery; 2010 Aug; 67(2):278-85. PubMed ID: 20562658
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.